Memorial Sloan Kettering Cancer Center Announces Visionary Gift From the Commonwealth Foundation for Cancer Research
Memorial Sloan Kettering Cancer Center (MSK) today announced a transformative gift from the Commonwealth Foundation for Cancer Research to benefit the Center for Experimental Therapeutics, a multidisciplinary research and drug development group at MSK. With this gift, the Commonwealth Foundation for Cancer Research continues their nearly three-decade commitment to the Center for Experimental Therapeutics, which was initially founded in 2002 with a generous gift from the Foundation.